{"cord_uid": "htoexg53", "sourcedb": "PMC", "sourceid": "PMC6316859", "divid": "29", "text": "Finally , the MVA - MERS - N vector virus generated for this study proved to be a stable recombinant virus that can be readily amplified to obtain vaccine preparations technically fulfilling all requirements for further preclinical or even clinical development . Future work with MVA - MERS - N candidate vaccines should help to elucidate the potential protective capacity of N - specific immune responses in MERS - CoV infections models and contribute to our better understanding of MERS vaccine - induced protection .", "project": "cdlai_CORD-19", "denotations": [{"id": 1, "span": {"begin": 20, "end": 25}, "obj": "ne"}, {"id": 2, "span": {"begin": 280, "end": 284}, "obj": "ne"}]}